Esperion Therapeutics, Inc.
24 clinical trials · Sponsor
◉ Watch Esperion Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women (NCT06021951) | Esperion Therapeutics, Inc. | 2023-08-04 |
| A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) (NCT05694260) | Esperion Therapeutics, Inc. | 2023-01-12 |
| Bempedoic Acid Pregnancy Surveillance Program (NCT05103254) | Esperion Therapeutics, Inc. | 2021-09-01 |
| Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C (NCT03531905) | Esperion Therapeutics, Inc. | 2018-05-09 |
| A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy (NCT03337308) | Esperion Therapeutics, Inc. | 2017-10-23 |
Track Esperion Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.